In addition, the expression of CXCL9/10/11/13 in primary tumor samples was remarkably higher than normal samples, whereas CXCL2/3/4/6/7/8/12/17 transcription levels were significantly lower (all P < 0.05) (Fig. 1b). This evidence concerns the gene CXCL2 and neoplasm.